Flavor Genes in Yeast Undergo CRISPR Grafting to Produce Rosier Wines, More Honied Beers – Genetic Engineering & Biotechnology News (press release)
Genetic Engineering & Biotechnology News (press release) |
Flavor Genes in Yeast Undergo CRISPR Grafting to Produce Rosier Wines, More Honied Beers
Genetic Engineering & Biotechnology News (press release) “The causative genes were identified by reciprocal allele swapping into both parents using clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9,” the article’s authors explained. “The superior allele of the first major causative gene … |
Genetic Engineering & Biotechnology News (press release) |
Flavor Genes in Yeast Undergo CRISPR Grafting to Produce Rosier Wines, More Honied Beers
Genetic Engineering & Biotechnology News (press release) “The causative genes were identified by reciprocal allele swapping into both parents using clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9,” the article’s authors explained. “The superior allele of the first major causative gene … |
|
International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson’s …
GlobeNewswire (press release) CARLSBAD, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that its … |
|
International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson’s …
GlobeNewswire (press release) CARLSBAD, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that its … |
Endpoints News |
Amgen bets on stem cell company Fortuna Fix in $25M round
Endpoints News The company says it’s reproduced this phenomena in test tubes by starting with regular old multipotent stem cells, which can be taken from any tissue (hair, skin, bone marrow, etc.) and re-engineered into neural stem cells. There’s a name for this kind … Amgen makes regenerative medicine play, backing $25M Fortuna …FierceBiotech |
Muscular Dystrophy News |
FDA Clears IND Application for Micro-dystrophin Gene Therapy Program to Treat Duchenne
Muscular Dystrophy News The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application for a micro-dystrophin gene therapy program by Sarepta Therapeutics and Nationwide Children’s Hospital, in clinical development for Duchenne muscular … |